Metraipolis › archive › dc_bd0a2c102da4
Differential Effects of Pre-Stroke Antithrombotic Medication on Clinical Outcomes of Patients with Hyperhomocysteinemia and First-Ever Stroke Versus Recurrent… — Europe PMC PMID:41096062
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41096062
- DOI
- 10.3390/jcm14196984
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T14:46:12.970Z
- SHA-256 of the archived text
5dbfebc7550ef92b56840a77306cefaab372dbe866c0f7d3a36a548b5914a3b5- Stable URL of this page
https://metraipolis.com/documento/dc_bd0a2c102da4
How to cite
Differential Effects of Pre-Stroke Antithrombotic Medication on Clinical Outcomes of Patients with Hyperhomocysteinemia and First-Ever Stroke Versus Recurrent… — Europe PMC PMID:41096062 — Europe PMC (en), https://europepmc.org/article/MED/41096062 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bd0a2c102da4 (Metraipolis archive dc_bd0a2c102da4, sha256 5dbfebc7550ef92b56840a77306cefaab372dbe866c0f7d3a36a548b5914a3b5)
BibTeX
@misc{dcbd0a2c102da4,
title = {Differential Effects of Pre-Stroke Antithrombotic Medication on Clinical Outcomes of Patients with Hyperhomocysteinemia and First-Ever Stroke Versus Recurrent… — Europe PMC PMID:41096062},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41096062},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bd0a2c102da4; sha256 5dbfebc7550ef92b56840a77306cefaab372dbe866c0f7d3a36a548b5914a3b5},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41096062. Agents can read the archived copy with the MCP tool read_document.